全文获取类型
收费全文 | 932篇 |
免费 | 48篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 20篇 |
妇产科学 | 40篇 |
基础医学 | 250篇 |
口腔科学 | 6篇 |
临床医学 | 83篇 |
内科学 | 142篇 |
皮肤病学 | 14篇 |
神经病学 | 61篇 |
特种医学 | 25篇 |
外科学 | 95篇 |
综合类 | 1篇 |
预防医学 | 121篇 |
眼科学 | 9篇 |
药学 | 81篇 |
肿瘤学 | 30篇 |
出版年
2022年 | 18篇 |
2021年 | 19篇 |
2020年 | 17篇 |
2019年 | 20篇 |
2018年 | 22篇 |
2017年 | 9篇 |
2016年 | 19篇 |
2015年 | 22篇 |
2014年 | 18篇 |
2013年 | 26篇 |
2012年 | 35篇 |
2011年 | 30篇 |
2010年 | 35篇 |
2009年 | 17篇 |
2008年 | 29篇 |
2007年 | 18篇 |
2006年 | 34篇 |
2005年 | 22篇 |
2004年 | 16篇 |
2003年 | 24篇 |
2002年 | 29篇 |
2001年 | 27篇 |
2000年 | 18篇 |
1999年 | 22篇 |
1998年 | 13篇 |
1997年 | 12篇 |
1996年 | 10篇 |
1993年 | 10篇 |
1992年 | 10篇 |
1991年 | 16篇 |
1990年 | 20篇 |
1989年 | 30篇 |
1988年 | 29篇 |
1987年 | 23篇 |
1986年 | 32篇 |
1985年 | 23篇 |
1984年 | 9篇 |
1980年 | 9篇 |
1979年 | 15篇 |
1978年 | 12篇 |
1975年 | 11篇 |
1974年 | 8篇 |
1973年 | 9篇 |
1972年 | 20篇 |
1971年 | 13篇 |
1970年 | 15篇 |
1969年 | 11篇 |
1968年 | 11篇 |
1967年 | 8篇 |
1966年 | 8篇 |
排序方式: 共有980条查询结果,搜索用时 15 毫秒
81.
82.
V. N. Timchenko E. B. Pavlova T. M. Chernova S. L. Bannova T. I. Savel’eva S. A. Tarasov M. V. Kachanova M. A. Siver’yanova 《Bulletin of experimental biology and medicine》2009,148(2):291-294
Addition of anaferon (pediatric formulation) to the therapy of chickenpox patients led to more rapid disappearance of the
main symptoms and alleviated the course of the disease. The safety of the preparation is confirmed by the absence of undesirable
events and stability of laboratory indexes against the background of therapy. 相似文献
83.
Savvateeva-Popova E Popov A Grossman A Nikitina E Medvedeva A Molotkov D Kamyshev N Pyatkov K Zatsepina O Schostak N Zelentsova E Pavlova G Panteleev D Riederer P Evgen'ev M 《Journal of neural transmission (Vienna, Austria : 1996)》2008,115(12):1629-1642
At most, many protein-misfolding diseases develop as environmentally induced sporadic disorders. Recent studies indicate that
the dynamic interplay between a wide repertoire of noncoding RNAs and the environment play an important role in brain development
and pathogenesis of brain disorders. To elucidate this new issue, novel animal models which reproduce the most prominent disease
manifestations are required. For this, transgenic Drosophila strains were constructed to express small highly structured, non-coding RNA under control of a heat shock promoter. Expression
of the RNA induced formation of intracellular aggregates revealed by Thioflafin T in embryonic cell culture and Congo Red
in the brain of transgenic flies. Also, this strongly perturbed the brain control of locomotion monitored by the parameters
of sound production and memory retention of young 5-day-old males. This novel model demonstrates that expression of non-coding
RNA alone is sufficient to trigger neuropathology. 相似文献
84.
Delev D Pavlova A Heinz S Blaise MC Chandra T Poetsch B Seifried E Oldenburg J 《Thrombosis and haemostasis》2008,100(5):766-772
Human coagulation factor V (FV), a non-enzymatic cofactor of the prothrombinase complex, is required for the rapid generation of thrombin. FV deficiency is a rare autosomal recessive bleeding disorder. We describe two novel mutations, Tyr91Asn and Asp2098Tyr, found in two probands with a residual FV activity of 51% and 4%, respectively. Modelling and structural analysis of these mutations were performed following short-duration molecular dynamics (MD) simulation. Asp2098Tyr lead to abolishment of the highly conserved salt bridge Asp2098-Arg2171 presumably required for structural integrity of the C2 domain. MD studies suggest that additional conformational changes resulting from this mutation involve local rearrangements at Tyr2063 and Tyr2064 and so affect the phospholipid-membrane binding. MD modelling of the Try91Asn mutant revealed a conformational change nearby the Cu(2+) binding site that could affect overall stabilization of the heavy and light chains. These findings suggest that both mutations influence the structural integrity of FV protein. Transient expression data of wild-type and mutant FV variants in 293T human embryonic kidney cells showed FV-specific activity reduced to 26% for Asp2098Tyr and 56% for Tyr91Asn compared to that of wild-type. Thus, both the data from the short duration molecular dynamic simulation and from expression analysis indicate alterations of the FV protein variants that explain the clinical phenotype. 相似文献
85.
Synthesis of Betulinic Acid from Betulin Extract and Study of the Antiviral and Antiulcer Activity of Some Related Terpenoids 总被引:1,自引:0,他引:1
Flekhter O. B. Nigmatullina L. R. Baltina L. A. Karachurina L. T. Galin F. Z. Zarudii F. S. Tolstikov G. A. Boreko E. I. Pavlova N. I. Nikolaeva S. N. Savinova O. V. 《Pharmaceutical Chemistry Journal》2002,36(9):484-487
Pharmaceutical Chemistry Journal - 相似文献
86.
The genes encoding effector molecules of mature T cells, IL-2, perforin and
IL-4, were found to be expressed in vivo in the most primitive subsets of
thymocytes of adult mice. These subsets have previously been identified by
their cell surface markers and by their expression of other T
lineage-associated genes. While IL-2, perforin and IL-4 are expressed in
distinct patterns, all three are expressed before the induction of RAG-1
and pre-TCR alpha mRNA expression, and are confined to subsets of cells
that apparently have not yet undergone commitment to the T lineage. Thus,
expression of T cell response genes appears to be one of the earliest
markers of lymphocyte differentiation. Activation events marked by CD69
induction occur in these early cell types, but the response gene expression
by these cells is separable from CD69 expression. IL-2 and perforin are
induced again much later in thymocyte development, during TCR-dependent
repertoire selection. At those stages, IL-2 protein and RNA levels per cell
are higher, but the fraction of cells expressing IL-2 appears to be much
lower than in the most immature stages. In addition, a striking feature of
the immature populations is the robust IL-2 expression by presumptive
immature NK cells. These findings are discussed in terms of the
developmental origins of lineage specificity in T cell response gene
regulation.
相似文献
87.
88.
Tsodikov GV Isakov VA Seliverstova TR Bogomolov PO Shakhovskiĭ IuK Pavlova TV Mironova OS Banina VB Kazantseva IA Gushchin AE 《Klinicheskaia meditsina》2003,81(2):54-57
The efficacy of monotherapy with one of the analogues of synthetic nucleosides (lamivudine) was studied in 22 patients with chronic viral hepatitis B (CVHB). The specific feature of the selected group was that there was no serum HBeAg, which is usually regarded as a sign of viral mutation. The time course of changes in the activity of blood and hepatic inflammatory processes and viral replication were studied at equal intervals. There was a direct correlation between the suppression of viral replication and the regression of activity indices, such as ALT, serological markers, DNA of viral hepatitis B, and the morphological constituents of the Knodell index) during lamivudine therapy. However, there were no substantial changes in the parameters of fibrosis throughout the treatment. Therapy resistance was revealed in 3 of the 22 patients with CVHV. Its basis was the mutation of hepatitis B virus in the YMDD-motive, which was detected in 2 of the 3 patients. 相似文献
89.
Behnaz?PezeshkpoorView authors OrcID profile Katrin?J.?Czogalla Michael?Caspers Ann-Cristin?Berkemeier Kerstin?Liphardt Suvoshree?Ghosh Marco?Kellner Silvia?Ulrich Anna?Pavlova Johannes?OldenburgEmail author 《Annals of hematology》2018,97(6):1061-1069
One of the most common and unwanted side effects during oral anticoagulant therapy (OAT) is bleeding complications. In rare cases, vitamin K antagonist (VKA)-related bleeding events are associated with mutations affecting the F9 propeptide at amino acid position 37 due to a substitution of alanine to either valine or threonine. Based on our actual cohort of 18 patients, we update the knowledge on this rare phenotype and its origin. A founder mutation for both variants was reconfirmed by haplotype analysis of intronic and extragenic short tandem repeat (STR) polymorphisms with a higher prevalence in Switzerland than in other regions of Europe. Screening of healthy individuals for the presence of these F9 gene mutations did not identify any of these variants, thus proving the rare occurrence of this genotype. Furthermore, both variants were expressed in vitro and warfarin dose responses were studied. Our warfarin dose response analysis confirmed higher sensitivity of both variants to warfarin with the effect being more apparent for Ala37Thr. Thus, although F9 propeptide mutation-associated hypersensitivity to VKA is a rare phenomenon, awareness towards this bleeding phenotype is important to identify patients at risk. 相似文献
90.